Trial Profile
Ability of Intranasal Transmucosal Fentanyl Pectin Nasal Spray to Prevent Breakthrough Pain Episodes in Patients With Radiation-induced Oropharyngeal Mucositis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2015
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 16 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Mar 2014 New trial record